SPECIAL COMMUNICATION

Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal

D M Burns¹, E Dybing², N Gray³, S Hecht⁴, C Anderson¹, T Sanner⁵, R O’Connor⁶, M Djordjevic⁷, C Dresler⁸, P Hainaut⁹, M Jarvis¹⁰, A Opperhuizen¹¹, K Straif⁹

¹ UCSD School of Medicine, San Diego, California, USA
² Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway
³ Cancer Council of Victoria, Melbourne, Victoria, Australia
⁴ University of Minnesota Cancer Center, Minneapolis, Minnesota, USA
⁵ Department of Environmental and Occupational Cancer, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
⁶ Roswell Park Research Institute, Buffalo, New York, USA
⁷ Tobacco Control Research Branch, National Cancer Institute, Bethesda, Maryland, USA
⁸ Arkansas Department of Health, Little Rock, Arkansas, USA
⁹ International Agency for Research on Cancer, Lyon, France
¹⁰ Royal Free and University College London Medical School, London, UK
¹¹ National Institute of Public Health and the Environment (RIVM), The Netherlands

Correspondence to:
D Burns, 1120 Solana Drive, Del Mar, California 92014, USA; dburns@ucsd.edu

Received 6 November 2007

Accepted 19 December 2007

The first 150 words of the full text of this article appear below.

Preventing initiation of tobacco product use, promoting cessation of tobacco use, and protecting the public from exposure to second hand smoke are recognised by the World Health organization (WHO) Framework Convention on Tobacco Control (FCTC) and by the WHO Study Group on Tobacco Product Regulation (TobReg) as the most effective approaches to reducing tobacco related morbidity and mortality. However, the FCTC also recognises the need for tobacco product regulation in articles 9 and 10 of the treaty. In order to inform that process TobReg has developed a series of reports that begin to provide a scientific foundation for tobacco product regulation.^1–6 This paper summarises a proposal, and the considerations that led to it, developed by a joint International Agency for Research on Cancer (IARC) and WHO working group, and approved by TobReg, which presents performance standards for cigarettes and a strategy to use them to mandate a reduction in the . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Benefits and risks in ending regulatory exceptionalism for tobacco

Simon Chapman
Tob. Control 2008 17: 73-74. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Zeller, M., Hatsukami, D., and the Strategic Dialogue on Tobacco Harm Reducti, (2009). The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tobacco Control 18: 324-332 [Abstract] [Full Text]  
• Liberman, J., Heyward, M. (2008). Use of the precautionary principle in the debate about emissions limits: a cautionary note. Tobacco Control 17: 286-287 [Full Text]  
• Gray, N. (2008). A letter from Nigel Gray. Tobacco Control 17: 287-288 [Full Text]  
• Chapman, S. (2008). Benefits and risks in ending regulatory exceptionalism for tobacco. Tobacco Control 17: 73-74 [Full Text]  

eLetters:

Read all eLetters

Use of the precautionary principle in the debate about emissions limits

Jonathan D Liberman, et al.

Tobacco Control Online, 9 Apr 2008 [Full text]

Regulation and precautions

Nigel J Gray

Tobacco Control Online, 11 Apr 2008 [Full text]

Regulation and precautions

Jonathan D Liberman, et al.

Tobacco Control Online, 13 Apr 2008 [Full text]